Works matching DE "PERHEXILINE"

Results: 32

Single crystalline phase photochemical properties and structure of a new biindenylidenedione bearing cyclohexyl groups.

Published in:

Research on Chemical Intermediates, 2004, v. 30, n. 4/5, p. 537, doi. 10.1163/1568567041280854

By:

Song, Zhi-Yi;
Xu, Li-Li;
Han, Jie;
Yu-Xin;
Meng, Ji-Ben

Publication type:

Article

Drugs that Affect Cardiac Metabolism: Focus on Perhexiline.

Published in:

Cardiovascular Drugs & Therapy, 2016, v. 30, n. 4, p. 399, doi. 10.1007/s10557-016-6664-3

By:

Chong, Cher-Rin;
Sallustio, Benedetta;
Horowitz, John

Publication type:

Article

Immobilization of α-[di-(Β-chloroethyl)-amide]-N-(m-nitrobenzoyl)-D,L-asparagic Acid on Xanthan.

Published in:

Journal of Biomaterials Applications, 2003, v. 18, n. 2, p. 83, doi. 10.1177/088532803032827

By:

Marcel, Popa;
Lacramioara, Balaita Rusu;
Valeriu, Sunel

Publication type:

Article

Development of a regimen for rapid initiation of perhexiline therapy in acute coronary syndromes.

Published in:

Internal Medicine Journal, 2004, v. 34, n. 6, p. 361, doi. 10.1111/j.1445-5994.2004.00624.x

By:

Philpott, A.;
Chandy, S.;
Morris, R.;
Horowitz, John D.

Publication type:

Article

Stereoselective pharmacokinetics of perhexiline

Published in:

Xenobiotica, 1986, v. 16, n. 5, p. 491

By:

Parke, D. V.;
Amoah, A. G. B.;
Gould, B. J.

Publication type:

Article

Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats.

Published in:

Toxicology Mechanisms & Methods, 2009, v. 19, n. 8, p. 477, doi. 10.1080/15376510903322834

By:

Miyamoto, Saku;
Matsumoto, Akemi;
Mori, Ikuo;
Horinouchi, Akira

Publication type:

Article

Calcium Antagonists in the Treatment of Individuals with Ischemic Heart Disease.

Published in:

Angiology, 1982, v. 33, n. 8, p. 522, doi. 10.1177/000331978203300804

By:

Winniford, Michael D.;
Willerson, James T.;
Hillis, L. David

Publication type:

Article

PERHEXILINE MALEATE, A NEW ANTI-ANGINAL DRUG, EVALUATED BY "MODIFIED DOUBLE BLIND DOUBLE CROSS OVER STUDY"

Published in:

Angiology, 1974, v. 25, n. 6, p. 406

By:

Datey, K. K.;
Dalvi, C. P.;
Kelkar, P. N.;
Bhootra, R. K.

Publication type:

Article

Ca-dependent Functions in Peptidoglycan-stimulated Mouse Dendritic Cells.

Published in:

Cellular Physiology & Biochemistry (Karger AG), 2009, v. 24, n. 3/4, p. 167, doi. 10.1159/000233243

By:

Xuan, NguyenThi;
Shumilina, Ekaterina;
Matzner, Nicole;
Zemtsova, Irina M.;
Biedermann, Tilo;
Goetz, Friedrich;
Lang, Florian

Publication type:

Article

Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart Failure.

Published in:

Diseases, 2017, v. 5, n. 2, p. 14, doi. 10.3390/diseases5020014

By:

Steggall, Abbey;
Mordi, Ify R.;
Lang, Chim C.

Publication type:

Article

Selective extraction of platinum, iridium, and palladium with macrocyclic endo-receptors from hydrochloric acid solutions.

Published in:

Russian Journal of General Chemistry, 2011, v. 81, n. 9, p. 1966, doi. 10.1134/S1070363211090428

By:

Yakshin, V.;
Vilkova, O.;
Tananaev, I.;
Myasoedov, B.

Publication type:

Article

Drug-induced fatty liver disease: An overview of pathogenesis and management.

Published in:

Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2015, v. 14, n. 6, p. 789, doi. 10.5604/16652681.1171749

By:

Satapathy, Sanjaya K.;
Kuwajima, Vanessa;
Nadelson, Jeffrey;
Atiq, Omair;
Sanyal, Arun J.

Publication type:

Article

Modulating fatty acid oxidation in heart failure.

Published in:

Cardiovascular Research, 2011, v. 90, n. 2, p. 202, doi. 10.1093/cvr/cvr038

By:

Lionetti, Vincenzo;
Stanley, William C.;
Recchia, Fabio A.

Publication type:

Article

Multi-centre experience on the use of perhexiline in chronic heart failure and refractory angina: old drug, new hope.

Published in:

European Journal of Heart Failure, 2009, v. 11, n. 9, p. 881, doi. 10.1093/eurjhf/hfp106

By:

Phan, Thanh Trung;
Shivu, Ganesh Nallur;
Choudhury, Anirban;
Abozguia, Khalid;
Davies, Chris;
Naidoo, Ulasini;
Ahmed, Ibrar;
Yousef, Zaheer;
Horowitz, John;
Frenneaux, Michael

Publication type:

Article

Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexiline.

Published in:

British Journal of Clinical Pharmacology, 2008, v. 65, n. 3, p. 347, doi. 10.1111/j.1365-2125.2007.03015.x

By:

Davies, Benjamin J.;
Herbert, Megan K.;
Coller, Janet K.;
Somogyi, Andrew A.;
Milne, Robert W.;
Sallustio, Benedetta C.

Publication type:

Article

The influence of CYP2D6 genotype on trough plasma perhexiline and cis-OH-perhexiline concentrations following a standard loading regimen in patients with myocardial ischaemia.

Published in:

British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 321, doi. 10.1111/j.1365-2125.2005.02570.x

By:

Davies, Benjamin J.;
Coller, Janet K.;
James, Heather M.;
Somogyi, Andrew A.;
Horowitz, John D.;
Sallustio, Benedetta C.

Publication type:

Article

Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexiline.

Published in:

British Journal of Clinical Pharmacology, 2004, v. 57, n. 4, p. 456, doi. 10.1046/j.1365-2125.2003.02033.x

By:

Davies, Benjamin J. L.;
Coller, Janet K.;
James, Heather M.;
Gillis, David;
Somogyi, Andrew A.;
Horowitz, John D.;
Morris, Raymund G.;
Sallustio, Bendetta C.

Publication type:

Article

Concentration-time profile for perhexiline and hydroxyperhexiline in patients at steady state.

Published in:

British Journal of Clinical Pharmacology, 2004, v. 57, n. 3, p. 263, doi. 10.1046/j.1365-2125.2003.02003.x

By:

Jones, Terry E.;
Morris, Raymond G.;
Horowitz, John D.

Publication type:

Article

Polymorphic hydroxylation of perhexiline in vitro.

Published in:

British Journal of Clinical Pharmacology, 2003, v. 55, n. 6, p. 635, doi. 10.1046/j.1365-2125.2003.01805.x

By:

Sørensen, L. B.;
Sørensen, R. N.;
Miners, J. O.;
Somogyi, A. A.;
Grgurinovich, N.;
Birkett, D. J.

Publication type:

Article

Pharmacokinetics of the antianginal agent perhexiline: relationship between metabolic ratio and steady-state dose.

Published in:

British Journal of Clinical Pharmacology, 2002, v. 54, n. 2, p. 107, doi. 10.1046/j.1365-2125.2002.01618.x

By:

Sallustio, Benedetta C.;
Westley, Ian S.;
Morris, Raymond G.

Publication type:

Article

Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems.

Published in:

PLoS Neglected Tropical Diseases, 2016, v. 10, n. 8, p. 1, doi. 10.1371/journal.pntd.0004928

By:

Guidi, Alessandra;
Lalli, Cristiana;
Perlas, Emerald;
Bolasco, Giulia;
Nibbio, Martina;
Monteagudo, Edith;
Bresciani, Alberto;
Ruberti, Giovina

Publication type:

Article

Screen for Chemical Modulators of Autophagy Reveals Novel Therapeutic Inhibitors of mTORC1 Signaling.

Published in:

PLoS ONE, 2009, v. 4, n. 9, p. 1, doi. 10.1371/journal.pone.0007124

By:

Balgi, Aruna D.;
Fonseca, Bruno D.;
Donohue, Elizabeth;
Tsang, Trevor C. F.;
Lajoie, Patrick;
Proud, Christopher G.;
Nabi, Ivan R.;
Roberge, Michel

Publication type:

Article

Multicentre double-blind randomized controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery.

Published in:

European Journal of Cardio-Thoracic Surgery, 2015, v. 48, n. 3, p. 354, doi. 10.1093/ejcts/ezu452

By:

Senanayake, Eshan L.;
Howell, Neil J.;
Ranasinghe, Aaron M.;
Drury, Nigel E.;
Freemantle, Nick;
Frenneaux, Michael;
Oelofse, Tessa;
Green, David;
Wilson, Ian C.;
Rooney, Stephen J.;
Mascaro, Jorge;
Graham, Timothy R.;
Bhudia, Sunil;
Lewis, Michael;
Pagano, Domenico

Publication type:

Article

The effect of perhexiline on myocardial protection during coronary artery surgery: a two-centre, randomized, double-blind, placebo-controlled trial.

Published in:

European Journal of Cardio-Thoracic Surgery, 2015, v. 47, n. 3, p. 464

By:

Drury, Nigel E.;
Howell, Neil J.;
Calvert, Melanie J.;
Weber, Ralf J.M.;
Senanayake, Eshan L.;
Lewis, Michael E.;
Hyde, Jonathan A.J.;
Green, David H.;
Mascaro, Jorge G.;
Wilson, Ian C.;
Graham, Timothy R.;
Rooney, Stephen J.;
Viant, Mark R.;
Freemantle, Nick;
Frenneaux, Michael P.;
Pagano, Domenico

Publication type:

Article

Effect of dicyclohexylcarbodiimide (DCCD) on transport parameters in the frog cornea epithelium.

Published in:

2000

By:

Carrasquer, G.;
Li, M.;
Dinno, M.A.

Publication type:

journal article

499 Metabolic modulation with perhexiline in chronic heart failure

Published in:

2004

By:

Lee, L.;
Scheuermann-Freestone, M.;
Campbell, R.;
Field, R.;
Gunaruwan, P.;
Horowitz, J.;
Clarke, K.;
Frenneaux, M.

Publication type:

Abstract

NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation.

Published in:

Journal of Enzyme Inhibition & Medicinal Chemistry, 2013, v. 28, n. 1, p. 95, doi. 10.3109/14756366.2011.636360

By:

Gatto, Gregory J.;
Ao, Zhaohui;
Kearse, Michael G.;
Zhou, Mei;
Morales, Cyndi R.;
Daniels, Erin;
Bradley, Benjamin T.;
Goserud, Matthew T.;
Goodman, Krista B.;
Douglas, Stephen A.;
Harpel, Mark R.;
Johns, Douglas G.

Publication type:

Article

Harnessing Genetics to Improve Cardiovascular Care.

Published in:

MD Conference Express, 2011, p. 6, doi. 10.1177/155989771115001

By:

Vinall, Maria

Publication type:

Article

Extraction of microamounts of strontium into nitrobenzene by using hydrogen dicarbollylcobaltate in the presence of dicyclohexyl-18-crown-6.

Published in:

Journal of Radioanalytical & Nuclear Chemistry, 2006, v. 267, n. 2, p. 471, doi. 10.1007/s10967-006-0078-9

By:

Valentová, Z.;
Vaňura, P.;
Makrlík, E.

Publication type:

Article

Perhexiline promotes HER3 ablation through receptor internalization and inhibits tumor growth.

Published in:

Breast Cancer Research, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13058-015-0528-9

By:

Xiu-Rong Ren;
Jiangbo Wang;
Takuya Osada;
Mook Jr., Robert A.;
Morse, Michael A.;
Barak, Larry S.;
Lyerly, Herbert Kim;
Wei Chen

Publication type:

Article

Comparison of CYP2D metabolism and hepatotoxicity of the myocardial metabolic agent perhexiline in Sprague-Dawley and Dark Agouti rats.

Published in:

Xenobiotica, 2015, v. 45, n. 1, p. 3, doi. 10.3109/00498254.2014.942721

By:

Licari, Giovanni;
Somogyi, Andrew A.;
Milne, Robert W.;
Sallustio, Benedetta C.

Publication type:

Article

Dicyclohexylphthalate causes hyperactivity in the rat concomitantly with impairment of tyrosine hydroxylase immunoreactivity.

Published in:

Journal of Neurochemistry, 2004, v. 91, n. 1, p. 69, doi. 10.1111/j.1471-4159.2004.02696.x

By:

Masami Ishido;
Yoshinori Masuo;
Junko Sayato-Suzuki;
Syuichi Oka;
Etsuo Niki;
Masatoshi Morita

Publication type:

Article